We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOLN:NASDAQMolecular Partners AG analysis

Data as of Oct 13, 2026 - not real-time

Latest price
$3.73
Risk: high
9/10High risk

Summary

Molecular Partners AG trades at $3.73, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 17.1% over the past 30 days. Relative strength is 37.5 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at $3.53 and resistance at $4.72.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 178.1% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 62.0%, a beta of 0.28 and a maximum drawdown of 27.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 1/10 long-term conviction.

Top market events

  • DLL3-targeting Radio-DARPin MP0712 progressing in Phase 1/2a trial, now recruiting at dose level 2; initial data...
  • Taiwan News3monMolecular Partners Showcases Bispecific Radio-DARPins at Gordon Research ConferencePresentation outlines...

Market outlook

Short term

< 1 year

Cautious

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 4.21
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 4.21
  • Analyst targets imply +178.1% versus the current price

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +178.1% versus the current price
  • Negative return on equity of -62.0%
  • Negative free cash flow

Key metrics

Financial health

P/E Ratio-23.0
ROE-61.97%
ROA-32.27%
Debt/Equity5.20
P/B Ratio2.0
Op. Cash Flow$-46113000
Free Cash Flow$-27040624
Industry P/E30.2

Technical analysis

TrendBearish
RSI37.5
Support$3.53
Resistance$4.72
MA 20$3.97
MA 50$4.15
MA 200$4.21
MACDBearish
VolumeIncreasing
Fear & Greed Index93.8

Valuation

Target Price$10.37
Upside/Downside178.11%
GradeFair
TypeBlend

Risk assessment

Beta0.28
Volatility61.98%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.